Direktorat Registrasi ObatValid

ACETAZOLAMIDE

Claim this product
BPOM Number
GKL2506323810A1
Approved
1 October 2025
Expiry
30 September 2030
Form
Tablet

About This Registration

ACETAZOLAMIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2506323810A1. Its current registration status is Valid, with the licence valid until 30 September 2030. The product is registered to ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA. BPOM first approved this registration in September 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 10 STRIP @ 10 TABLET
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Manufacturing Sites

Ingredients (1)

ACETAZOLAMIDE

Market Intelligence

Owner Portfolio
ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA holds 157 BPOM registrations
Manufacturer Scale
ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA produces 157 registered products
Registration Age
Registered for 11 months

FDA Cross-Reference

via openFDA
Generic Name
ACETAZOLAMIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA

CHLORAMPHENICOL

-GKL9106305031A1
Valid
Approved: Jul 27, 2026SALEP MATA
View product →

LACYVIR

-DKL1506317031A1
Valid
Approved: Dec 4, 2025SALEP MATA
View product →

ERFLOX

-DKL2506324360A1
Valid
Approved: Nov 21, 2025TETES MATA DAN TELINGA
View product →

MOXIFLOXACIN HYDROCHLORIDE

-GKL2506324446A1
Valid
Approved: Nov 17, 2025TETES MATA
View product →

ERLADERM-G

-DKL2106320829A1
Valid
Approved: Nov 1, 2025KRIM
View product →

Products in the same class

TARMESON

-DKL2540505229A1
Valid
Approved: Mar 16, 2026KRIM
BETA PHARMACON - INDONESIA
View product →

BERTHAMOL

-DTL2138600604A1
Valid
Approved: Dec 12, 2025KAPLET
SATRIA BUMIKERTA - AMIDA FARMA - INDONESIA
View product →

GUAIFENESIN

-GTL0307114410A1
Valid
Approved: Aug 1, 2025TABLET
PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA
View product →

MYLANTA

-DBL1441200163A1
Valid
Approved: Jul 21, 2025TABLET KUNYAH
INTEGRATED HEALTHCARE INDONESIA - INDONESIA
View product →

XILERGY

-DTL1413025037A1
Valid
Approved: Jul 18, 2025SIRUP
KONIMEX - INDONESIA
View product →
1